Epionce

Our Company

Episciences, Inc, was founded in 2002 and is based in Boise, Idaho. Episciences, Inc, integrates twenty-plus years of research into the development of a highly effective cosmeceutical, non-prescription, dermatological product line. This breakthrough product has been proven effective by over 12 independent clinical studies to reverse and prevent the effects of visible skin aging and certain common skin diseases.

Epionce is a comprehensive and innovative skin wellness line designed to optimize the appearance and health of the skin by working at the core of the skin's own protective and reparative systems. Combining a unique sub-layer delivery system and patent-pending botanical formulations, Epionce is a new paradigm in skin wellness delivering:

Powerful Therapy: Epionce strengthens your skin's own mechanisms, helping to improve function, restore the barrier and reverse destructive skin inflammation— delivering you beautiful, healthy skin.

Patent Pending Formulations: Epionce unique therapeutic skin treatments contain patented active ingredient complexes for common skin diseases, conditions and aging.

Proven Results: The effectiveness of Epionce has been proven in double-blind clinical trials conducted by independent, nationally recognized research organizations.

Based on a solid scientific approach, the Epionce product line is retailed through dermatologists, plastic surgeons and other skin care professionals interested in improving the overall health of the skin and quality of life of their patients.

Our Founder

Dr. Carl R. Thornfeldt is President, CEO, and Chief Scientific Officer of the United States- based partner to Episciences Europe LLP, Episciences, Inc. He is a practicing dermatologist with 25 years of skin research experience, 22 U.S. patents granted and over 20 scientific publications in the area of treatment of skin diseases and conditions, including chapters in five dermatological textbooks. Along with these accomplishments, he has also spent nearly two decades focusing on researching the skin barrier and cutaneous inflammatory conditions.

Dr. Thornfeldt received his M.D. from the Oregon Health Sciences University. Soon after, he spent three years in family practice for the U.S. Navy, and completed his dermatology residency at University Hospital, San Diego, California. While running his private practice and conducting research, Dr. Thornfeldt has co-founded and held the position of CEO at several privately and publicly held companies.

Currently, Dr. Thornfeldt is an Assistant Clinical Professor of Dermatology at the University of Oregon Health Sciences Center. He has presented at numerous international, national and regional scientific meetings including, most recently, the 2008 American Academy of Cosmetic Surgery. This spring his most recent textbook chapter will be released.

In 2003 and 2005, Dr. Thornfeldt was selected as one of the top 50 doctors in the U.S. by The Sinatra Health Report. He is the only dermatologist on the list.